In the bladder cancer patient prediction model established by Zhang et al., COL6A1 was a hub gene whose high expression was associated with poorer OS in bladder cancer patients, and the expression of COL6A1 was significantly higher in metastatic bladder cancer tissues compared to non‐metastatic tissues.42 The gene discussed is COL6A1; the disease is urinary bladder carcinoma.